V. Moreno

Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study

Matteo Simonelli, Elena Garralda, Ferry A.L.M. Eskens et al. · ESMO Open · 2022 · 25 citations · Full text

IL-6 as a Biomarker of Ischemic Cerebrovascular Disease

V. Moreno, Dolores Subirá, Elena Meseguer et al. · Biomarkers in Medicine · 2008 · 16 citations · Full text

Il-6 Genotype, Vascular Disease, Immunology +22

Dostarlimab for the treatment of endometrium cancer and other solidtumors

Jaime Rubio, Raquel Hernández, T. Hernandez et al. · Drugs of today · 2021 · 13 citations

Phase I study of cemiplimab, a human monoclonal anti-PD-1, in patients with unresectable locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Longer follow-up efficacy and safety data

T. K. Owonikoko, K. Papadopoulos, Melissa L. Johnson et al. · Annals of Oncology · 2018 · 11 citations · Full text

Dose escalation study of OMO-103, a first in class Pan-MYC-Inhibitor in patients (pts) with advanced solid tumors

Elena Garralda, V. Moreno, G. Alonso et al. · European Journal of Cancer · 2022 · 10 citations · Full text

Class Pan-myc-inhibitor, Medicine, Pharmacology +8